Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Optimi Health ( (TSE:OPTI) ) just unveiled an update.
Optimi Health Corp. is set to finalize a non-brokered private placement, issuing 131,666 units to raise CAD$395,000, with insiders participating. The proceeds will be used for general working capital and the offering involves a related party transaction. Additionally, Optimi is settling a CAD$98,126.25 debt with two creditors by issuing common shares, with both transactions expected to close by January 24, 2025.
More about Optimi Health
Optimi Health Corp. is a Health Canada-licensed, GMP-compliant manufacturer specializing in natural psilocybin and MDMA. The company focuses on producing high-quality psychedelic products to support global mental health therapies through compliance, innovation, and collaboration.
YTD Price Performance: 7.14%
Average Trading Volume: 72,763
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$21.3M
For detailed information about OPTI stock, go to TipRanks’ Stock Analysis page.
